Comparing Xeljanz vs Xeljanz XR
Xeljanz (tofacitinib) | Xeljanz XR (tofacitinib) |
|
---|
Xeljanz (tofacitinib) | Xeljanz XR (tofacitinib) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Xeljanz is a Janus kinase (JAK) inhibitor that may be used to reduce inflammation associated with several conditions such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, or... View more |
Prescription only
Prescribed for Ankylosing Spondylitis, Rheumatoid Arthritis, Ulcerative Colitis, Psoriatic Arthritis. Xeljanz XR may also be used for purposes not listed in this medication guide. |
Related suggestions Rheumatoid Arthritis
Ulcerative Colitis
Ankylosing Spondylitis
Popular comparisons
|
|||||||||||||||
More about Xeljanz (tofacitinib) | More about (tofacitinib) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Xeljanz has an average rating of 5.7 out of 10 from a total of 146 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 40% reported a negative effect. |
Xeljanz XR has an average rating of 6.4 out of 10 from a total of 17 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 35% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Xeljanz side effects |
View all Xeljanz XR side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Xeljanz prices |
View all Xeljanz XR prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Other tofacitinib brands include: Xeljanz Oral Solution, Xeljanz XR | Other tofacitinib brands include: Xeljanz, Xeljanz Oral Solution | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
3 hours |
3 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 677 drugs are known to interact with Xeljanz:
|
A total of 677 drugs are known to interact with Xeljanz XR:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
November 06, 2012 |
N/A |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
N/A |
|||||||||||||||||
Professional Resources | |||||||||||||||||
N/A |
|||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.